Estimation of lipoperoxidative damage and antioxidant status in diabetic children: Relationship with individual antioxidants

References

• Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997;82:291 —295.
   Google Scholar
• Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd ed. Oxford: Clarendon Press; 1999.
   Google Scholar
• Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 1992;119:598–620.
   Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease, cause, or consequence? Lancet 1994;344:721–724.
   PubMed Web of Science ®Google Scholar
• Wolff SP, Dean RT. Glucose autooxidation and protein modification. The potential role of "autoxidative glycosyl-ation" in diabetes. Biochem J 1987;245:243–250.
   Google Scholar
• Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315–1321.
   Google Scholar
• Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939–1945.
   Google Scholar
• Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and super-oxide anion generation in human aortic endothelial cells. Circulation 1997;96:25–28.
   PubMed Web of Science ®Google Scholar
• Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardó F, Sastre J, Villa J. Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes 2002;51: 1118–1124.
   Google Scholar
• Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van denEnden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic compli-cations. Diabetes 1993;42:801–813.
   PubMed Web of Science ®Google Scholar
• Dominguez C, Ruiz E, Gussinyé M, Carrascosa A. Oxidative stress at onset and in early stages of Type I Diabetes in children and adolescents. Diabetes Care 1998;21:736–742.
   Google Scholar
• Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephro-pathy. Diabetes 2000;12: 2170–2177.
   Google Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, Anderson HR. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Chin Chem 1997; 43:1209–1214.
   Google Scholar
• Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000;43:550–557.
   Google Scholar
• Pryor WA, Stanley JP, Blair E. Autoxidation of polyunsatu-rated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoper-oxides. Lipids 1976;11:370–379.
   Google Scholar
• Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984;105:328–331.
   PubMedGoogle Scholar
• Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorometric determination of malondialdehyde. Chin Chem 1991;37:1273–1275.
   Google Scholar
• Janero DR. Malondialdehyde and thiobarbituric acid-reacti vity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515–540.
   PubMed Web of Science ®Google Scholar
• Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation. Chin Chem 1988;34:2433–2438.
   Google Scholar
• Esterbauer H, Lang J, Zadravec S, Slater T. Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 1984;105:319–328.
   PubMed Web of Science ®Google Scholar
• Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993;15:353–363.
   PubMed Web of Science ®Google Scholar
• Wayner DDM, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total peroxyl radical-trapping antioxidant capacity of human blood plasma by controlled peroxidation. FEBS Lett 1985;187:33–37.
   PubMed Web of Science ®Google Scholar
• Glazer AN. Phycoerythrin fluorescence-based assay for reactive oxygen species. Methods Enzymol 1990;186: 161–168.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407–412.
   PubMed Web of Science ®Google Scholar
• Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993;14:303–311.
   PubMed Web of Science ®Google Scholar
• Ghiselli A, Serafini M, Maiani G, Azzini E, Ferro-Luzzi A. A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic Biol Med 1995; 18:29–36.
   PubMed Web of Science ®Google Scholar
• Chapple IL, Mason GI, Garner I, Matthews JB, Thorpe G, Maxwell SR. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Chin Biochem 1997;34:412–421.
   PubMedGoogle Scholar
• Fukunaga K, Suzuki T, Takama K. Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples. J Chromatogr 1993;621:77–81.
   Google Scholar
• Jordan P, Brubacher D, Moser U, Stähelin B, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Chin Chem 1995;41:924–927.
   Google Scholar
• Kontush A, Beisiegel U. Measurement of oxidizability of blood plasma. Methods Enzymol 1999;299:35–49.
   PubMed Web of Science ®Google Scholar
• Hu M-L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380–385.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• Packer L, Rosen P, Tritschler HJ, King GL, Azzi A. Antioxidants in Diabetes Management. New York, USA: Marcel Dekker, Inc; 2000.
   Google Scholar
• Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988;85:9748–9752.
   PubMed Web of Science ®Google Scholar
• Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981;78:6858–6862.
   PubMed Web of Science ®Google Scholar
• Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993;14:615–631.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11: 81–128.
   Google Scholar
• Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708–1716.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333–337.
   PubMed Web of Science ®Google Scholar
• Solberg LA, Strong JP. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 1983; 3:187–198.
   PubMedGoogle Scholar
• Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 1992;43:219–225.
   Google Scholar
• Kutuk 0, Basaga H. Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 2003;9: 549–557.
   Google Scholar
• Robertson R, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004;53:S119–S124.
   PubMedGoogle Scholar
• Llurba E, Gratacós E, Martin-Gallin P, Cabero Ll, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in pre-eclampsia and normal preg-nancy. Free Radic Biol Med 2004;37:557–570.
   PubMed Web of Science ®Google Scholar
• Gross M, Yu X, Hannan P, Prouty C, Jacobs Jr, DR. Lipid standardization of serum fat-soluble antioxidant concen-trations: The YALTA study. Am J Chin Nutr 2003;77: 458–466.
   PubMed Web of Science ®Google Scholar
• Krempf M, Ranganathan S, Ritz P, Morin M, Charbonnel B. Plasma vitamin A and E in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) adult diabetic patients. Int J Vitam Nutr Res 1991;61: 38–42.
   Google Scholar
• Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, Kato K, Nakazawa S. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993;15:597–602.
   PubMed Web of Science ®Google Scholar
• Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Chin Sci 1996;90:255–260.
   Google Scholar
• Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Chin Investig 1997;27:484–490.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995;44:1054–1058.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. Diabetes Care 1991;14:68–72.
   PubMed Web of Science ®Google Scholar
• Gazis A, Page S, Cocjcroft J. Vitamin E and cardiovascular protection in diabetes. Br Med J 1997;314:1845–1846.
   Google Scholar
• Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concen-trations in erythrocytes of type 1 diabetic children. Diabetes Care 2000;23: 1389–1394.
   Google Scholar
• Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1–8.
   PubMed Web of Science ®Google Scholar
• Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988;85:9748–9752.
   PubMed Web of Science ®Google Scholar
• Herman JB, Goldbourt U. Uric acid and diabetes: Obser-vations in a population study. Lancet 1982;2(8292):240–243.
   PubMedGoogle Scholar
• Shichiri M, Iwamoto H, Marumo F. Diabetic hypouricemia as an indicator of clinical nephropathy. Am J Nephrol 1990;10:115–122.
   Google Scholar
• Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: A case for gender difference. Diabetes Care 2002;25:370–375.
   PubMed Web of Science ®Google Scholar
• Dura Trave T, Moya Benavent M, Casero Ariza J. Renal hypouricemia in juvenile diabetes mellitus. An Esp Pediatr 1996;44:425–428.
   PubMedGoogle Scholar